Some very sad news to report out of Silicon Valley, where venture capitalist Nicola Campbell has passed away at the age of 37. She was serving as a partner with Sofinnova Ventures, and before that had been with BA Venture Partners (now Scale Venture Partners) and Burrill & Co. Her deals included Alimera Biosciences, Cellective Therapeutics, Marinus Pharma and Phenomix.
Nicola had begun her career as an immunologist, receiving her PhD from Mount Sinai Medical Center, and then working with Genentech. Part of her passion for the work was sparked by her own battle with Crohn’s Disease, although it is unclear if that condition led to her untimely passing.
I have not yet been able to connect with Sofinnova, but have spoken to others who knew Nicola far better than I. They all described her as cheerful and energetic, and noted how she had successfully launched a Bay Area program that connected life sciences VCs with area physicians and medical researchers.
Nicola will be buried in a ceremony in her native Canada. Her parents request that, in lieu of flowers, donations be made to the Crohn’s & Colitis Foundation of America. I also invite you to share remembrances of Nicola in the comment section below.